These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25721436)

  • 1. Uveitis in juvenile idiopathic arthritis.
    Heiligenhaus A; Minden K; Föll D; Pleyer U
    Dtsch Arztebl Int; 2015 Feb; 112(6):92-100, i. PubMed ID: 25721436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.
    Rypdal V; Glerup M; Songstad NT; Bertelsen G; Christoffersen T; Arnstad ED; Aalto K; Berntson L; Fasth A; Herlin T; Ekelund M; Peltoniemi S; Toftedal P; Nielsen S; Leinonen S; Bangsgaard R; Nielsen R; Rygg M; Nordal E;
    Ophthalmology; 2021 Apr; 128(4):598-608. PubMed ID: 32866542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
    Kotaniemi K; Sihto-Kauppi K; Salomaa P; Säilä H; Ristolainen L; Kauppi M
    Clin Exp Rheumatol; 2014; 32(1):143-7. PubMed ID: 24351424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
    Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
    Trials; 2014 Jan; 15():14. PubMed ID: 24405833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
    Ramanan AV; Guly CM; Keller SY; Schlichting DE; de Bono S; Liao R; Quartier P
    Trials; 2021 Oct; 22(1):689. PubMed ID: 34627340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
    Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):703-716. PubMed ID: 31021540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile arthritis-associated uveitis: visual outcomes and prognosis.
    Chen CS; Roberton D; Hammerton ME
    Can J Ophthalmol; 2004 Oct; 39(6):614-20. PubMed ID: 15559647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uveitis in juvenile idiopathic arthritis].
    Foeldvari I; Walscheid K; Heiligenhaus A
    Z Rheumatol; 2017 Oct; 76(8):664-672. PubMed ID: 28812127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
    Heiligenhaus A; Klotsche J; Tappeiner C; Sengler C; Niewerth M; Liedmann I; Hoeft S; Walscheid K; Lavric M; Foell D; Minden K
    Rheumatology (Oxford); 2019 Jun; 58(6):975-986. PubMed ID: 30590748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study.
    Siiskonen M; Hirn I; Pesälä R; Ohtonen P; Hautala N
    Pediatr Rheumatol Online J; 2023 Jun; 21(1):56. PubMed ID: 37322490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile idiopathic arthritis-associated uveitis.
    Sen ES; Ramanan AV
    Clin Immunol; 2020 Feb; 211():108322. PubMed ID: 31830532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany.
    Heiligenhaus A; Klotsche J; Niewerth M; Horneff G; Ganser G; Haas JP; Minden K
    Arthritis Res Ther; 2020 Apr; 22(1):81. PubMed ID: 32293540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the Treatment of Uveitis in Patients with Juvenile Idiopathic Arthritis: A Review.
    Asproudis I; Katsanos A; Kozeis N; Tantou A; Konstas AG
    Adv Ther; 2017 Dec; 34(12):2558-2565. PubMed ID: 29143927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    Haasnoot AJ; Vernie LA; Rothova A; V D Doe P; Los LI; Schalij-Delfos NE; de Boer JH
    PLoS One; 2016; 11(10):e0164312. PubMed ID: 27723840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?
    Mastrangelo G; Foeldvari I; Anton J; Simonini G
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):40. PubMed ID: 31296236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort.
    Morelle G; Gueudry J; Uettwiller F; Wouters C; Bader-Meunier B; Robert MP; Monnet D; Bodaghi B; Grall-Lerosey M; Quartier P
    RMD Open; 2019; 5(2):e000933. PubMed ID: 31452929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
    Papadopoulou M; Zetterberg M; Oskarsdottir S; Andersson Grönlund M
    Acta Ophthalmol; 2017 Nov; 95(7):741-747. PubMed ID: 28205413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases.
    Hayworth JL; Turk MA; Nevskaya T; Pope JE
    Joint Bone Spine; 2019 Nov; 86(6):685-690. PubMed ID: 31207292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.